Nurix Therapeutics Inc Cash Flow Reinvestment Rate
Nurix Therapeutics Inc cash flow reinvestment rate. Nurix Therapeutics Inc (NRIX) has a Cash Flow Reinvestment Rate of 0.64x as of November 2023, reinvesting $16.96 Million (capex $2.58 Million plus investments $-14.37 Million) from operating cash flow of $26.69 Million. See financial agility of Nurix Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Nurix Therapeutics Inc (2019–2019)
Cash flow reinvestment rate of Nurix Therapeutics Inc from 2019 to 2019. Historical reinvestment intensity for Nurix Therapeutics Inc across 1 annual periods. Explore cash flow to debt ratio of Nurix Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Nurix Therapeutics Inc Cash Flow Reinvestment Rate by Year (2019–2019)
Nurix Therapeutics Inc cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Nurix Therapeutics Inc. For the full cash flow conversion analysis, see Nurix Therapeutics Inc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 16.89x | $10.15 Million | $601.00K | $1.65 Million | — |